论文部分内容阅读
目的:探讨分析沙丁胺醇、酮替芬治疗咳嗽变异性哮喘的临床疗效,为临床治疗提供借鉴。方法:选择于2012年1月~2012年12月到我院进行治疗的70例咳嗽变异性哮喘患者作为观察组,采作为用沙丁胺醇联合酮替芬治疗;另外选择70例患者对照组患者采用氨茶碱联合扑尔敏治疗。2周后对2组患者的临床疗效进行比较分析。结果:观察组患者在治疗后经统计显示,14例有效(20.0%),53例显效(75.7%),3例无效(4.3%)总有效率为95.7%;对照组患者中有22例为有效(31.4%),32例为显效(45.7%),16例无效(22.9%),总有效率为77.1%;经比较我们可看出观察组患者的临床疗效明显优于对照组,且差异有统计学意义(P<0.05)。结论:能够及早发现病症并进行正确诊断,正规服药,对于咳嗽变异性哮喘的治疗有重要的意义。沙丁胺醇、酮替芬治疗咳嗽变异性哮喘具有良好的临床效果,而且患者病症复发率低,适合在临床推广应用。
Objective: To investigate the clinical efficacy of albuterol and ketotifen in the treatment of cough variant asthma, and provide references for clinical treatment. Methods: Seventy patients with cough variant asthma who were treated in our hospital from January 2012 to December 2012 were selected as the observation group and treated with salbutamol combined with ketotifen. In the other 70 patients, the patients in the control group were treated with ammonia Theophylline combined with chlorpheniramine treatment. Two weeks later, the clinical efficacy of two groups of patients were compared. Results: After treatment, the statistics showed that in 14 patients (20.0%), 53 patients (75.7%) and 3 patients (4.3%), the total effective rate was 95.7%; in the control group, 22 patients were (31.4%), 32 cases were markedly effective (45.7%), 16 cases were ineffective (22.9%), the total effective rate was 77.1%; by comparison we can see that the clinical efficacy of observation group was significantly better than the control group, and the difference There was statistical significance (P <0.05). Conclusion: Being able to detect the disease as soon as possible and correctly diagnose it, taking the medicine regularly, is of great significance for the treatment of cough variant asthma. Salbutamol, ketotifen cough variant asthma has a good clinical effect, and patients with low recurrence rate, suitable for clinical application.